Zhejiang Shengda Bio-Pharm Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 788.5 million compared to CNY 860.26 million a year ago. Revenue was CNY 789.73 million compared to CNY 867.31 million a year ago. Net income was CNY 75.76 million compared to CNY 197.44 million a year ago. Basic earnings per share from continuing operations was CNY 0.44 compared to CNY 1.17 a year ago. Diluted earnings per share from continuing operations was CNY 0.44 compared to CNY 1.17 a year ago.